Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 829 results for "ema"

Biocon jumps 4.5%
India Infoline

Biocon jumps 4.5%

The EMA has accepted for review Biocon and Mylan's Marketing Authorization Application for a proposed biosimilar Trastuzumab, used to treat certain breast and gastric cancers. India Infoline, 4 days ago

918 images for ema

Malay Mail, 2 days ago
New Vision, 19 hours ago
Odisha Television, 2 days ago, 5 days ago
Business Standard India, 5 days ago
VOA News, 4 days ago
MySarawak, 5 days ago
Borneo Post Online, 5 days ago
Pharma Letter, 5 days ago
Malay Mail, 1 week ago

Stocks in focus: Biocon, Welspun India

Biocon shares hit a record high as EMA has agreed to review Biocon-Mylan cancer drug. The stock gained as much as 5.11 per cent to a record high of Rs 909.80. It ended higher by 3.1 per cent at Rs 892.45 on the BSE. European Medicines Agency had on Thursday ...
 Business Line5 days ago Biocon hits fresh record high as EMA accepts biosimilar for review  Business Standard5 days ago

13/08/2016 - UK-London: Service concession in the area of pharmacovigilance training - EMA/2016/43/RS

This page lists the European Medicines Agency's (EMA's) current calls for tender with a value over €135,000. As of March 2015, the EMA is part of an eTendering platform for managing calls for tender, which consists of the publication of tender ...
 European Medicines Agency2 weeks ago 08/08/2016 - UK-London: Supply and disposal of catering equipment including appliances - EMA/2016/22/DF  European Medicines Agency3 weeks ago

Crude Oil Technicals: MCX Futures Need To Hold Above 20 Day EMA

MCX Crude oil futures witnessed an impressive upward move yesterday. The counter tested a high above the 20 day EMA and ended above the same, also breaking above Rs 2900 per barrel levels. The contract ended just above Rs 2910 per barrel, rising ...
 India Infoline2 weeks ago Gold Technicals: MCX Futures Extend Choppy Moves  India Infoline2 weeks ago Copper Technicals: MCX Futures Look Choppy  India Infoline2 weeks ago

EMA Adopts Biologics Pharmacovigilance Practices

The agency has adopted guidelines on the pharmacovigilance of biological drugs. The European Medicines Agency (EMA) announced on August 15, 2016 that it was adopting a new chapter on biologics in its guidelines on good pharmacovigilance practices ...
 PharmTech.com2 weeks ago

Biocon up over 5% post Q1 results, EMA review of Biosimilar

The stock surged 7% to Rs 749 after the company reported 35% YoY jump in its consolidated net profit of Rs 167 crore in Q1.
 Business Standard1 month ago EMA India reports standalone net loss of Rs 2.35 crore in the June 2016 quarter  Business Standard1 month ago

News and press releases: Data integrity: key to public health protection

11/08/2016 Data integrity: key to public health protection New guidance now available on EMA's website The European Medicines Agency (EMA) has released new good manufacturing practice (GMP) guidance to ensure the integrity of data that are ...
 European Medicines Agency2 weeks ago Data integrity: key to public health protection  Pharmacy Choice2 weeks ago EMA - Data integrity: key to public health protection EMA - Data integrity: key to public health protection  Pharmacy Choice2 weeks ago

Stock Trend Indicator Pro

Buy-Sell Signals, MACD, SMA, EMA, News, Alert Notifications and much more. INSTALL NOW and get a FREE 7-DAY TRIAL. WARNINGTHIS IS NOT A FREE APP. It uses Google Play in-app subscription as a mode of payment. During the 7-day trial period, no charges ...
 ZDNet2 weeks ago

EMA approves Cardiome Pharma's Xydalba single dose infusion

Cardiome Pharma Corp., a specialty pharmaceutical company, announced that Xydalba (dalbavancin) has been approved by the European Medicines Agency (EMA) for administration as a single, 30 minute, 1500mg infusion (three 500mg vials). This single ...
 PharmaBiz2 weeks ago EMA approves single dose administration of Cardiome Pharma's XYDALBA  Pharmaceutical Business Review2 weeks ago Cardiome Pharma Corp. Announces XYDALBA Single Dose Infusion Approval By EMA  BioSpace2 weeks ago Cardiome Announces XYDALBA Single Dose Infusion Approval by European Medicines Agency  Yahoo! Canada3 weeks ago
GM Journal

PCI Biotech receives positive opinion from EMA

PCI Biotech has announced that it has received a positive opinion from the European Medicine Agency's (EMA) Committee for Orphan Medicinal Products (COMP) for its lead product candidate, fimaporfin, for the treatment of cholangiocarcinoma (bile duct ...
 Nordic Life Science2 weeks ago Cabometyx and Kisplyx provide additional treatment options for patients with renal cell carcinoma  GM Journal2 weeks ago Science : Masitinib Receives from EMA Orphan Drug Designation in the European Union for Amyotrophic Lateral Sclerosis (ALS)  4 Traders3 weeks ago SCIENCE : AB Science announces that Masitinib receives from European Medicines Agency (EMA) Orphan Drug Designation in the European Union for Amyotrophic Lateral Sclerosis (ALS)  4 Traders3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ema
Get updated on latest news & your favorite topics right in your inbox!
More     Less